BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25873280)

  • 1. Abnormal expression of Forkhead Box J2 (FOXJ2) suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis.
    Qiang Y; Wang F; Yan S; Zhang H; Zhu L; Chen Z; Tu F; Wang D; Wang G; Wang W; Chen Z
    Int J Oncol; 2015; 46(6):2449-58. PubMed ID: 25873280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANXA8 down-regulation by EGF-FOXO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma.
    Lee MJ; Yu GR; Yoo HJ; Kim JH; Yoon BI; Choi YK; Kim DG
    Gastroenterology; 2009 Sep; 137(3):1138-50, 1150.e1-9. PubMed ID: 19376120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of FoxJ2 in the migration of human glioma cells.
    Qiu X; Ji B; Yang L; Huang Q; Shi W; Ding Z; He X; Ban N; Fan S; Zhang J; Tian Y
    Pathol Res Pract; 2015 May; 211(5):389-97. PubMed ID: 25661068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
    Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
    BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of forkhead box J2 can decrease the migration of breast cancer cells.
    Wang Y; Yang S; Ni Q; He S; Zhao Y; Yuan Q; Li C; Chen H; Zhang L; Zou L; Shen A; Cheng C
    J Cell Biochem; 2012 Aug; 113(8):2729-37. PubMed ID: 22441887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.
    Watanabe A; Suzuki H; Yokobori T; Altan B; Kubo N; Araki K; Wada S; Mochida Y; Sasaki S; Kashiwabara K; Hosouchi Y; Kuwano H
    Cancer Sci; 2013 Nov; 104(11):1427-32. PubMed ID: 23919841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.
    Zhang Z; Meng G; Wang L; Ma Y; Guan Z
    Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
    Xu Y; Wang Z; Jiang X; Cui Y
    Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXJ2 Inhibits the Proliferation, Migration and Epithelial-Mesenchymal Transition of Prostate Carcinoma Cells.
    Guo G; Zhu L
    Ann Clin Lab Sci; 2022 Sep; 52(5):731-740. PubMed ID: 36261186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin.
    Zhang H; Tang QF; Sun MY; Zhang CY; Zhu JY; Shen YL; Zhao B; Shao ZY; Zhang LJ; Zhang H
    Cell Death Dis; 2018 Sep; 9(9):916. PubMed ID: 30206221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
    Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
    Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
    EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
    Qin X; Lu M; Zhou Y; Li G; Liu Z
    Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
    Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.